DD298883A5 - Verwendung von steroiden zur herstellung von arzneimitteln - Google Patents
Verwendung von steroiden zur herstellung von arzneimitteln Download PDFInfo
- Publication number
- DD298883A5 DD298883A5 DD90340770A DD34077090A DD298883A5 DD 298883 A5 DD298883 A5 DD 298883A5 DD 90340770 A DD90340770 A DD 90340770A DD 34077090 A DD34077090 A DD 34077090A DD 298883 A5 DD298883 A5 DD 298883A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- steroid
- antiestrogen
- gestodene
- use according
- combination preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3916381A DE3916381A1 (de) | 1989-05-17 | 1989-05-17 | Verwendung von gestoden zur herstellung von arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD298883A5 true DD298883A5 (de) | 1992-03-19 |
Family
ID=6381002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD90340770A DD298883A5 (de) | 1989-05-17 | 1990-05-17 | Verwendung von steroiden zur herstellung von arzneimitteln |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0399631B1 (pt) |
| JP (1) | JPH0386826A (pt) |
| CN (1) | CN1047298A (pt) |
| AT (1) | ATE101519T1 (pt) |
| AU (1) | AU640139B2 (pt) |
| CA (1) | CA2016895A1 (pt) |
| DD (1) | DD298883A5 (pt) |
| DE (2) | DE3916381A1 (pt) |
| DK (1) | DK0399631T3 (pt) |
| ES (1) | ES2062312T3 (pt) |
| HU (1) | HUT54501A (pt) |
| IE (1) | IE65717B1 (pt) |
| IL (1) | IL94417A (pt) |
| PT (1) | PT94051B (pt) |
| ZA (1) | ZA903803B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| FR2833837B1 (fr) * | 2001-12-21 | 2005-08-05 | Oreal | Composition pour la teinture d'oxydation des fibres keratiniques comprenant un amide d'acide gras de colza oxyethylene |
| JP4775563B2 (ja) * | 2006-03-31 | 2011-09-21 | Ｎｏｋ株式会社 | センターベアリングサポート |
| JP2009078123A (ja) | 2007-09-07 | 2009-04-16 | Morito Co Ltd | 取付部品と取付対象物との連結方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
-
1989
- 1989-05-17 DE DE3916381A patent/DE3916381A1/de not_active Withdrawn
-
1990
- 1990-05-16 IL IL9441790A patent/IL94417A/en not_active IP Right Cessation
- 1990-05-16 PT PT94051A patent/PT94051B/pt not_active IP Right Cessation
- 1990-05-16 CA CA002016895A patent/CA2016895A1/en not_active Abandoned
- 1990-05-16 HU HU903055A patent/HUT54501A/hu unknown
- 1990-05-17 CN CN90103702A patent/CN1047298A/zh active Pending
- 1990-05-17 AU AU55135/90A patent/AU640139B2/en not_active Ceased
- 1990-05-17 ZA ZA903803A patent/ZA903803B/xx unknown
- 1990-05-17 DE DE69006633T patent/DE69006633T2/de not_active Expired - Lifetime
- 1990-05-17 IE IE177590A patent/IE65717B1/en not_active IP Right Cessation
- 1990-05-17 AT AT90250128T patent/ATE101519T1/de not_active IP Right Cessation
- 1990-05-17 DD DD90340770A patent/DD298883A5/de not_active IP Right Cessation
- 1990-05-17 DK DK90250128.7T patent/DK0399631T3/da active
- 1990-05-17 EP EP90250128A patent/EP0399631B1/en not_active Expired - Lifetime
- 1990-05-17 JP JP2125615A patent/JPH0386826A/ja active Pending
- 1990-05-17 ES ES90250128T patent/ES2062312T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE101519T1 (de) | 1994-03-15 |
| DK0399631T3 (da) | 1994-06-06 |
| PT94051A (pt) | 1991-01-08 |
| CA2016895A1 (en) | 1990-11-17 |
| HU903055D0 (en) | 1990-09-28 |
| HUT54501A (en) | 1991-03-28 |
| IL94417A0 (en) | 1991-03-10 |
| AU640139B2 (en) | 1993-08-19 |
| DE69006633D1 (de) | 1994-03-31 |
| CN1047298A (zh) | 1990-11-28 |
| IL94417A (en) | 1995-07-31 |
| AU5513590A (en) | 1990-11-29 |
| ES2062312T3 (es) | 1994-12-16 |
| DE69006633T2 (de) | 1994-08-25 |
| IE901775L (en) | 1990-11-17 |
| ZA903803B (en) | 1991-03-27 |
| EP0399631A1 (en) | 1990-11-28 |
| EP0399631B1 (en) | 1994-02-16 |
| IE65717B1 (en) | 1995-11-15 |
| JPH0386826A (ja) | 1991-04-11 |
| DE3916381A1 (de) | 1990-11-22 |
| PT94051B (pt) | 1996-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60209907T2 (de) | Verwendung von oestrogenverbindungen zur steigerung der libido bei frauen | |
| EP0310541B1 (de) | Antigestagen- und antiöstrogenwirksame Verbindungen zur Geburtseinleitung und zum Schwangerschaftsabbruch sowie zur Behandlung gynäkologischer Störungen | |
| DE19619045C1 (de) | Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen | |
| DE60216630T2 (de) | Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie | |
| DE69333023T2 (de) | 3-beta-hydroxylierte natürliche Steroidderivate enthaltende Arzneimittelzusammensetzungen und ihre Verwendung | |
| DE69731473T2 (de) | Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen | |
| DE69022722T2 (de) | Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen. | |
| DE69327319T2 (de) | Minimierung von mit progesteron verbundenen durchbruckblutungen | |
| LU83545A1 (de) | Verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie | |
| DE69133077T2 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
| EP0310542B1 (de) | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren | |
| JPH05117144A (ja) | 皮膚の萎縮軽減剤、およびその使用法 | |
| DE69006633T2 (de) | Verwendung von Gestoden zur Herstellung von Arzneimitteln. | |
| DE10051609A1 (de) | Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen | |
| EP1978970B1 (de) | Kontrazeptivum | |
| DE3607651A1 (de) | Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer | |
| Barnes et al. | Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism | |
| EP0630248B1 (de) | Verwendung von östriol zur herstellung einen transdermalen therapeutischen systeme zur behandlung von klimakterischer osteoporose | |
| EP1415653A2 (de) | Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese | |
| EP0495825B1 (de) | Verwendung von antigestagenen zur herstellung von arzneimitteln | |
| DE19510862A1 (de) | Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle | |
| Samojlik et al. | Medical hormone ablation in men with advanced prostate cancer | |
| Iqbal et al. | Binding of 17α-ethinyl-13β-ethyl-17β-hydroxy-4, 15-gonadiene-3-one (gestoden), a new synthetic progestogen, to human circulating binding proteins and oestrogen receptor (ER), in normal and malignant tissue | |
| Braunsberg et al. | Studies of human breast cancer cells escaping from control by growth-inhibitory hormones | |
| WO2007104576A1 (de) | Arzneimittel enthaltend n-acetyl-mannosamin oder derivate hiervon und seine verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VZ | Disclaimer of patent (art. 11 and 12 extension act) |